Profusa (PFSA) Receivables - Other (2021 - 2025)
Profusa's (PFSA) quarterly Receivables - Other came in at $428000.0 in Q3 2025, up 1612.0% quarter-over-quarter from $25000.0 in Q1 2022.
Profusa (PFSA) Receivables - Other (2021 - 2025) Analysis & Trends
Profusa's Receivables - Other history runs 3 years deep, the most recent figure standing at $428000.0 for Q3 2025.
- On a quarterly basis, Receivables - Other changed N/A year-over-year to $428000.0 in Q3 2025; TTM through Sep 2025 was $428000.0, a N/A change from a year earlier, with the FY2024 full-year figure at -$45000.0, changed N/A from the prior year.
- Receivables - Other improved to $428000.0 in Q3 2025 per PFSA's latest filing, from $25000.0 in the prior quarter.
- Across five years, Receivables - Other topped out at $428000.0 in Q3 2025 and bottomed at $25000.0 in Q4 2021.
- The 3-year median for Receivables - Other is $25000.0 (2021), against an average of $159333.3.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | Profusa | 23,566.40 | -351,433.60 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 428,000.00 |
| Sep 30, 2025 | 428,000.00 |
| Mar 31, 2022 | 25,000.00 |
| Mar 31, 2022 | 25,000.00 |
| Dec 31, 2021 | 25,000.00 |
| Dec 31, 2021 | 25,000.00 |